An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis

For lupus nephritis (LN) management, it is very important to detect fibrosis at an early stage. Urinary exosomal miRNAs profiling can be used as a potential multi-marker phenotyping tool to identify early fibrosis. We isolated and characterised urinary exosomes and cellular pellets from patients with biopsy-proven LN (n = 45) and healthy controls (n = 20). LN chronicity index (CI) correlated with urinary exosomal miR-21, miR-150, and miR-29c (r = 0.565, 0.840, −0.559, respectively). This miRNA profile distinguished low CI from moderate-high CI in LN patients with a high sensitivity and specificity (94.4% and 99.8%). Furthermore, this multimarker panel predicted an increased risk of progression to end-stage renal disease (ESRD). Pathway analysis identified VEGFA and SP1 as common target genes for the three miRNAs. Immunohistochemistry in LN renal biopsies revealed a significant increase of COL1A1 and COL4A1 correlated with renal chronicity. SP1 decreased significantly in the high-CI group (p = 0.002). VEGFA levels showed no differences. In vitro experiments suggest that these miRNA combinations promote renal fibrosis by increasing profibrotic molecules through SP1 and Smad3/TGFβ pathways. In conclusion, a urinary exosomal multimarker panel composed of miR-21, miR-150, and miR-29c provides a non-invasive method to detect early renal fibrosis and predict disease progression in LN.

[1]  Systemic Lupus Erythematosus Disease Activity Index , 2020, Definitions.

[2]  P. Udagama,et al.  Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study , 2019, BMC Neurology.

[3]  A. Gholaminejad,et al.  Identification of candidate microRNA biomarkers in renal fibrosis: a meta-analysis of profiling studies , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  Wang Yi-li,et al.  Liquid biopsy biomarkers of renal interstitial fibrosis based on urinary exosome. , 2018, Experimental and molecular pathology.

[5]  Yang Zhou,et al.  Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis , 2018, Nephron.

[6]  J. Lv,et al.  A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis , 2018, International Urology and Nephrology.

[7]  M. Rots,et al.  TCTN2: a novel tumor marker with oncogenic properties , 2017, Oncotarget.

[8]  R. S. Conlan,et al.  Exosomes as Reconfigurable Therapeutic Systems. , 2017, Trends in molecular medicine.

[9]  D. Yap,et al.  Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis , 2017, F1000Research.

[10]  S. Beddhu,et al.  Extracellular microRNA signature in chronic kidney disease. , 2017, American journal of physiology. Renal physiology.

[11]  B. Rovin,et al.  Update on Lupus Nephritis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[12]  Saveria Mazzara,et al.  CombiROC: an interactive web tool for selecting accurate marker combinations of omics data , 2017, Scientific Reports.

[13]  Kathleen E. Sullivan,et al.  New insights into the immunopathogenesis of systemic lupus erythematosus , 2016, Nature Reviews Rheumatology.

[14]  C. Ponticelli,et al.  Lupus nephritis: When and how often to biopsy and what does it mean? , 2016, Journal of autoimmunity.

[15]  A. Józkowicz,et al.  TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation , 2016, Mediators of inflammation.

[16]  N. Zhang,et al.  miR‐410 suppresses the expression of interleukin‐6 as well as renal fibrosis in the pathogenesis of lupus nephritis , 2016, Clinical and experimental pharmacology & physiology.

[17]  M. Rudnicki,et al.  Renal microRNA‐ and RNA‐profiles in progressive chronic kidney disease , 2016, European journal of clinical investigation.

[18]  Paolo Aretini,et al.  The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management , 2015, BMC Cancer.

[19]  J. Ordi‐Ros,et al.  miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[21]  Jun Li,et al.  TGF-β/Smad signaling in renal fibrosis , 2015, Front. Physiol..

[22]  B. Carter,et al.  Extracellular vesicles as a platform for ‘liquid biopsy’ in glioblastoma patients , 2014, Expert review of molecular diagnostics.

[23]  Lesley Cheng,et al.  Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. , 2014, Kidney International.

[24]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[25]  P. Barbry,et al.  FibromiRs: translating molecular discoveries into new anti-fibrotic drugs. , 2014, Trends in pharmacological sciences.

[26]  L. Lv,et al.  MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. , 2013, American journal of physiology. Renal physiology.

[27]  Mingxia Xiong,et al.  Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells. , 2013, Experimental cell research.

[28]  G. Illei,et al.  miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. , 2013, Journal of the American Society of Nephrology : JASN.

[29]  S. Friedman,et al.  Therapy for Fibrotic Diseases: Nearing the Starting Line , 2013, Science Translational Medicine.

[30]  F. Marabita,et al.  Identification of New Autoantigens by Protein Array Indicates a Role for IL4 Neutralization in Autoimmune Hepatitis* , 2012, Molecular & Cellular Proteomics.

[31]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[32]  F. Hamdy,et al.  An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer , 2012, British Journal of Cancer.

[33]  U. Jeschke,et al.  Two-marker combinations for preoperative discrimination of benign and malignant ovarian masses. , 2012, Anticancer research.

[34]  R. Colvin,et al.  Renal interstitial fibrosis: mechanisms and evaluation , 2012, Current opinion in nephrology and hypertension.

[35]  F. Hamdy,et al.  Changes in circulating microRNA levels associated with prostate cancer , 2012, British Journal of Cancer.

[36]  E. Abraham,et al.  Identification of a microRNA signature in renal fibrosis: role of miR-21. , 2011, American journal of physiology. Renal physiology.

[37]  Glen McGillivary,et al.  Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. , 2011, Kidney international.

[38]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[39]  P. Boor,et al.  Renal fibrosis: novel insights into mechanisms and therapeutic targets , 2010, Nature Reviews Nephrology.

[40]  Gang Wang,et al.  Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy , 2010, Disease markers.

[41]  T. Kassimatis,et al.  Transcription Factor Sp1 Expression Is Upregulated in Human Glomerulonephritis: Correlation with pSmad2/3 and p300 Expression and Renal Injury , 2010, Renal failure.

[42]  N. Hirankarn,et al.  Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis. , 2009, Kidney international.

[43]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[44]  Pil Je Park,et al.  The multiplex bead array approach to identifying serum biomarkers associated with breast cancer , 2009, Breast Cancer Research.

[45]  F. Slack,et al.  Small non-coding RNAs in animal development , 2008, Nature Reviews Molecular Cell Biology.

[46]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[47]  Y. Tomino,et al.  Pravastatin Inhibits Carboxymethyllysine-Induced Monocyte Chemoattractant Protein 1 Expression in Podocytes via Prevention of Signalling Events , 2007, Nephron Experimental Nephrology.

[48]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[49]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[50]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[51]  D. Mason,et al.  Double immunofluorescence labelling of routinely processed paraffin sections , 2000, The Journal of pathology.

[52]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[53]  J. Klippel,et al.  Prognostic factors in lupus nephritis. Contribution of renal histologic data. , 1983, The American journal of medicine.

[54]  Jianguo Xia,et al.  miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context. , 2018, Methods in molecular biology.

[55]  R. Colvin,et al.  Renal Interstitial Fibrosis: Mechanisms and Evaluation In: Current Opinion in Nephrology and Hypertension , 2022 .